Firm Profile > Morrison & Foerster LLP > Shanghai, China
Morrison & Foerster LLP Offices
SUITE 3501-3502, BUND CENTRE
NO 222 YAN AN ROAD EAST
Morrison & Foerster LLP > The Legal 500 Rankings
Morrison & Foerster LLP’s PE practice consistently assists clients with a variety of high-value deals. It fields industry experts in technology, data centres, life sciences and healthcare, and education (particularly online education), who work alongside the firm's robust finance and restructuring practices. Of recent, the group experienced particular growth in relation to fintech-related transactions. The practice of Shanghai-based Ruomu Li, who joined from Fenwick & West LLP in 2019, includes complex PE transactions and venture capital investments, while Lucy (Qiong) Lu in Beijing, a recent hire from Dechert LLP, is also active in PE matters. Notable associate-level support on the mainland is provided by Tian Zhou, and Alice Li, whose practices include PE investments, along with Richard Ji, who focuses on PE transactions and VC investments. Two of the most experienced private equity lawyers in the Asian market, Thomas Chou and Marcia Ellis jointly lead the Asia PE practice from the firm's Hong Kong office.
Other key lawyers:
Softbank Vision Fund
NewQuest Capital Partners
Farallon Capital Asia
Bain Capital Credit
Ark Pacific Capital
TMT: foreign firms Tier 1Morrison & Foerster has a strong affiliation with TMT businesses and this continues to be true in Greater China, spread across its Hong Kong, Beijing and Shanghai offices. The China team has attracted engagements from a range of big-name Chinese and international TMT businesses, along with a large number of technology investors and start-ups. The firm works extensively in the fields of digital transformation and the development of proprietary technology. It frequently advises strategic investors on their investments in emerging technology businesses. It also has extensive experience in cybersecurity and data privacy. Gordon Milner leads the Asia TMT practice from Hong Kong. Shanghai partner Chuan Sun is regarded as a pure TMT lawyer and is highly rated for M&A and commercial matters. Hong Kong's Thomas Chou and Marcia Ellis are noted for private equity and venture capital investments in the technology sector. Beijing and Shanghai managing partner Paul McKenzie is another key figure.
‘I have used MoFo’s services in relation to technology agreements in China, and they are truly specialised in this field.’
‘Chuan Sun has very solid expertise in the commercial technology agreements field and not only does he provide commercial practical advice, he is also able to manage his team to learn our business and turn around contracts with speed and efficiency. His scope of expertise is impressive, ranging from hardware agreements, open source software, to on-premises and cloud services to privacy law related issues.’
Softbank Vision Fund
Morrison & Foerster LLP distinguishes itself through headline technology sector deals, including e-commerce and data centre-related transactions. The practice also fields experts in life sciences, healthcare, real estate and education (particularly online education), who are able to leverage the firm's robust finance and restructuring practices. Also of note is its fast-growing fintech practice. In Beijing, Lucy Lu focuses on a broad range of PRC-related corporate matters; and Shanghai-based Ruomu Li has extensive experience in advising strategic and financial investors on transactions in the technology and life sciences industries. Other key mainland China advisers are Beijing and Shanghai managing partner, Paul McKenzie, and Chuan Sun, who works across the Shanghai and Hong Kong offices, along with associates Tian Zhou, Alice Li, Richard Ji and Sarah Wang. Marcia Ellis and Thomas Chou co-head the Asia private equity practice from Hong Kong, where Vivian Yiu is a cross-border transactions specialist.
‘A professional team that is prompt to respond, considerate and flexible.‘
‘This very capable, intelligent team has deep experience. Client service is its biggest strength – it is our go-to adviser for complicated and time sensitive transactions.‘
‘Marcia Ellis is experienced, extremely capable, very hardworking, and understands our business.‘
Softbank Vision Fund
NewQuest Capital Partners
Farallon Capital Asia
Bain Capital Credit
Ark Pacific Capital
Fintech: foreign firms Tier 2
A go-to firm for technology investors and start-ups, Morrison & Foerster LLP's dedicated fintech team in Greater China regularly works alongside the firm's robust venture capital and private equity fund practices. It is particularly experienced in cybersecurity and data privacy matters, while its regulatory expertise covers the requirements under the payments, internet, and telecoms and cloud regulatory regimes. Managing partner of the Beijing and Shanghai offices, Paul McKenzie, consistently advises IT and other tech sector clients; and working across the Shanghai and Hong Kong offices, Chuan Sun focuses on fintech, cross-border M&A transactions and complex TMT transactions. Gordon Milner heads the China fintech practice from the Hong Kong office, where Thomas Chou, who co-heads the firm's Asia private equity and venture capital group, is also a key partner.
As one of Morrison & Foerster LLP's core areas of sector strength, it is perhaps unsurprising that life sciences-related work informs a significant volume of transactions handled out of its Greater China offices. The firm's Hong Kong office has excellent credentials for private equity and venture capital-related investor-side work within the sector and benefits from the ability to provide a holistic service which is conversant with the underlying science and IP considerations, as well as the corporate aspects of the transactions. The team is also able to leverage strong Silicon Valley credentials, of particular benefit for Chinese clients on outbound mandates and on potential US capital market exit strategies for funds which invested in the sector. Shanghai-based partner Chuan Sun has a focus on advising venture capital and private funds on their investments in the life sciences sector, and is also regularly engaged by international life sciences clients to advise on the regulatory issues associated with setting up in China.
Ally Bridge Group
Jiangsu Hengrui Medicine Co., Ltd.
Xingren (Trusted Doctors)
CBC Group (formerly C-Bridge Capital)
Everest Medicines Limited/Everest Medicines II Limited
Morrison & Foerster LLP's core expertise lies in private equity funds and real estate funds. The practice recently picked up new clients from the venture capital funds space, as well as several large bank and insurance company clients on the LP side. Hong Kong-based Serena Tan has extensive experience in the formation of, and investment in, private funds; and funds partner Nicholas Sheets joined as partner from Kirkland & Ellis in 2019.
Ally Bridge Group
China Great Wall Asset Management Co., Ltd.
Fosun International Group
FWD Group Management Holdings Ltd
GLP PTE, Ltd.
BHG Long Hills
SoftBank Ventures Asia
Silicon Valley Bank
Morrison & Foerster LLP's resident real estate team in Greater China stands out for its technology sector expertise; in relation to data centres throughout Asia, it consistently acts for a range of clients on all stages of the real estate investment cycle. Hong Kong's Marcia Ellis co-heads the firm's Asia private equity practice, and regularly works with leading real estate companies in the region; and Chuan Sun, who works across the Shanghai and Hong Kong offices, assists real estate companies with cross-border M&A transactions.
Morrison & Foerster is known for high-stakes, multi-jurisdictional disputes in sectors such as technology, energy, chemicals, construction, manufacturing, telecommunications, private equity and real estate. The litigation practice is led from Hong Kong by Timothy Blakely who focuses on government and internal investigations and complex commercial litigation, as does key partner Sarah Thomas. Its scope spans the entire Asia region, with the Beijing and Shanghai offices playing a key role in cases involving Chinese companies and multi-national entities with local interests. The firm's work spans commercial and IP disputes, investigations and compliance and privacy crisis response.
Headed by Hong Kong managing partner Timothy Blakely, Morrison & Foerster LLP's full-service China corporate investigations and anti-corruption practice is particularly focused on government investigations and prosecutions, internal investigations, and FCPA due diligence and advisory work. Blakely has represented multinational and Chinese clients in various industries, including telecoms, biotechnology, publishing, pharmaceuticals, and financial services.
Morrison & Foerster LLP > Firm Profile
The firm: With approximately 1,000 lawyers in 17 offices, Morrison & Foerster is a preeminent global law firm dedicated to delivering business-oriented results to clients across the United States, Asia and Europe. Dynamic technology and life science companies, large financial institutions, leading consumer product companies and other market leaders come to Morrison & Foerster for knowledge, innovation and business aptitude. Morrison & Foerster handles some of the world’s largest cross-border transactions and resolves major disputes across multiple jurisdictions. The firm has a long-standing commitment to pro bono work and social justice.
For more than 36 years Morrison & Foerster has been on the ground advising clients about their most important China-related matters. The China offices have more than 50 multilingual U.S.-, PRC-, and Hong Kong-qualified professionals, who work closely with attorneys throughout the firm to deliver calibrated and sound advice to clients.
The firm counsels a wide variety of clients in China on their high-profile investment, finance, and regulatory matters, including many of the world’s largest multinationals and the most substantial and active institutional PRC companies, as well as promising startups in the Internet, technology, entertainment, telecommunications, life sciences, energy, clean technology, and renewable energy industries.
Areas of practice: MoFo’s Shanghai office has served Chinese and international clients, including financial investors and institutions, the Fortune 500, institutional and state-owned PRC companies, entrepreneurs, and technology companies of all types. The Beijing and Shanghai offices include more than 10 U.S., PRC, Australian and Canadian-qualified attorneys, the majority of whom are fully bilingual.
Capital markets: MoFo’s leading capital markets practice in China regularly represents issuers and underwriters in debt and equity financings, as well as in domestic venture capital and private equity investments. It is one of the most active capital markets practices of any international law firm in the region, advising clients on a broad range of corporate financing matters involving Hong Kong, U.S. and English law. The firm’s multi-jurisdictional law capabilities and bilingual teams enhance its competitive position, representing clients on both international offerings and cross-border corporate finance matters.
Dispute resolution: MoFo is one of the world’s premier litigation firms. Its full-service Asia dispute resolution practice is a fully integrated regional practice, working seamlessly across its five offices in Asia, to handle all aspects of complex commercial litigation, international arbitration and predispute counselling matters.
Intellectual property and litigation: MoFo has extensive experience in representing Chinese companies in their IP disputes in the US and in the development of their global IP portfolios. MoFo has also been advising its global clients who seek to proactively protect their IP from infringement and misappropriation in China.
Mergers and acquisitions: MoFo’s China M&A practice combines senior PRC regulatory expertise with international deal execution capability. The firm’s lawyers in Beijing, Shanghai, and Hong Kong have significant PRC-related, as well as Asia-wide and global cross-border M&A experience.
Private equity and venture capital: combining corporate finance expertise with diverse technology, healthcare, life sciences and real estate practices, lawyers in MoFo’s Shanghai office are active in all aspects of the evolving private equity and venture capital market in China. The practice regularly represents private equity investors, venture capitalists, private equity fund sponsors and issuers in a wide variety of private equity transactions, including buyouts (leveraged and non-leveraged), early and late-stage venture investments and restructurings and recapitalisations.
Real estate: The China real estate practice team represents investors in the financing, acquisition, joint venture and development of real estate investments across China and internationally. The group has a robust practice representing real estate private equity firms, investment managers, sovereign wealth funds, development companies and REITs that invest in real estate assets and companies in this sector.
Technology transactions: MoFo has assisted leading media and IT companies, global banks and financial institutions, biotech companies and private equity funds in navigating legal, structuring and commercial challenges arising from handling technology projects in China’s rapidly evolving business and regulatory environment.
Investment Funds: MoFo’s Private Funds practice is widely recognized by fund sponsors and institutional investors as a leading group in Asia and globally. As one of the largest private funds practices in Asia, we represent fund sponsors and investors in the formation and operation of investment funds in a number of strategies. We are one of only a handful of law firms in Asia with the experience to effectively guide both GPs and LPs through the entire fund formation process.
FinTech: MoFo has long been recognized as a leading financial services and technology firm. Our Fintech practice is not just a corporate practice that happens to handle M&A deals in the very sector. We have one of the few dedicated operational Fintech teams in China, and our partners have nearly two decades of on-the-ground experience at the heart of one of the world’s fastest growing technology markets, catering to a stellar list of industry-leading companies who rely on us to help ensure the success of their most critical deals in mainland China and Hong Kong in a challenging political climate
Healthcare and Life Sciences: Leading life sciences investors and companies throughout the U.S., Europe, Japan, and China choose MoFo to help them enter, expand within, or grow outside of the Chinese life sciences market because of our experience in complex, cutting-edge cross-border commercial transactions and financings, our legendary scientific expertise in matters from IP strategic counseling to IP due diligence, and our long and storied track record working within the Chinese life science market.
|Anti-bribery/anti-corruption/FCPA||Timothy Blakelyfirstname.lastname@example.org||+852 25850870|
|Capital markets||Venantius (Ven) Tanemail@example.com||+852 25850836|
|Corporate governance and internal investigations||Timothy Blakelyfirstname.lastname@example.org||+852 25850870|
|Dispute resolution||Timothy Blakelyemail@example.com||+852 25850870|
|Foreign direct investment||Paul McKenziefirstname.lastname@example.org||+86 10 5909 3366|
|Intellectual property and litigation||Sarah Thomas||SarahThomas@mofo.com||+852 25850771|
|International arbitration||Timothy Blakelyemail@example.com||+852 25850870|
|Life sciences||Janet Xiaofirstname.lastname@example.org||+1 (650) 813-5736|
|Life sciences||Thomas Chouemail@example.com||+852 2585 0848|
|Life sciences||Chuan Sunfirstname.lastname@example.org||+86 21 2322 5243|
|Life sciences||Gordon Milneremail@example.com||+852 2585 0808|
|Mergers and acquisitions||Thomas Choufirstname.lastname@example.org||+852 2585 0848|
|Mergers and acquisitions||Marcia Ellisemail@example.com||+852 2585 0784|
|Mergers and acquisitions||Paul McKenziefirstname.lastname@example.org||+86 10 5909 3366|
|Mergers and acquisitions||Vivian Yiuemail@example.com||+852 2585 0761|
|Mergers and acquisitions||Ruomu Lifirstname.lastname@example.org||+86 21 2322 5218|
|Mergers and acquisitions||Lucy Luemail@example.com||+86 10 5909 3311|
|Private equity and venture capital||Thomas Choufirstname.lastname@example.org||+852 2585 0848|
|Private equity and venture capital||Marcia Ellisemail@example.com||+852 2585 0784|
|Real estate||Marcia Ellisfirstname.lastname@example.org||+852 2585 0784|
|Technology transactions||Gordon Milneremail@example.com||+852 2585 0808|
|Investment Funds||Serena Tan||STan@mofo.com||+852 2585 0861|
|Investment Funds||Nicholas Sheetsfirstname.lastname@example.org||+852 2585 0814|
|Fintech||Thomas Chouemail@example.com||+852 2585 0848|
|Fintech||Paul McKenziefirstname.lastname@example.org||+86 10 5909 3366|
|Fintech||Gordon Milneremail@example.com||+852 2585 0808|
|Fintech||Chuan Sunfirstname.lastname@example.org||+86 21 2322 5243|